Venous thrombosis and anticoagulant therapy
2001; Wiley; Volume: 114; Issue: 2 Linguagem: Inglês
10.1046/j.1365-2141.2001.02961.x
ISSN1365-2141
AutoresPier Mannuccio Mannucci, L. Poller,
Tópico(s)Vascular anomalies and interventions
ResumoBritish Journal of HaematologyVolume 114, Issue 2 p. 258-270 Venous thrombosis and anticoagulant therapy P. M. Mannucci, P. M. Mannucci Angelo Bianchi Bonomi Haemophilia and Thrombosis Centre, IRCCS Maggiore Hospital and University of Milan, Italy, and Search for more papers by this authorL. Poller, L. Poller Central Facility, European Concerted Action on Anticoagulation, School of Biological Sciences, Manchester University, UKSearch for more papers by this author P. M. Mannucci, P. M. Mannucci Angelo Bianchi Bonomi Haemophilia and Thrombosis Centre, IRCCS Maggiore Hospital and University of Milan, Italy, and Search for more papers by this authorL. Poller, L. Poller Central Facility, European Concerted Action on Anticoagulation, School of Biological Sciences, Manchester University, UKSearch for more papers by this author First published: 20 December 2001 https://doi.org/10.1046/j.1365-2141.2001.02961.xCitations: 28 P. M. Mannucci, Angelo Bianchi Bonomi Haemophilia and Thrombosis Centre, IRCCS Maggiore Hospital and University of Milan, via lace 9, Milan, Italy. E-mail: piermannuccio. [email protected] Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References Allaart, C.F. & Briët, E. (1994) Familial venous thrombophilia. In: Haemostasis and Thrombosis, 3rd edn. (ed. by A.L. Bloom, C.D. Forbes, D.P. Thomas & E.G.D. Tuddenham), p1349. Churchill Livingstone, London. Google Scholar Anderson, D., Harrison, L., Hirsh, J. (1993) Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy. Archives of Internal Medicine, 153, 1441–1447. CASPubMedWeb of Science®Google Scholar Anderson, Jr, F.A., Wheeler, H.B., Goldberg, R.J., Hosmer, D.W., Patwardhan, N.A., Jovanovic, B., Forcier, A., Dalen, J.E. (1991) A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Archives of Internal Medicine, 151, 933–938. 10.1001/archinte.1991.00400050081016 CASPubMedWeb of Science®Google Scholar Anning, S.T. (1957) The historical aspects of venous thrombosis. Medicine History, 1, 28–37. 10.1017/S0025727300020743 CASPubMedGoogle Scholar Baillie, J. (1793) Of uncommon appearances of disease in blood vessels. Transactions of the Society for the Improvement in Medical and Chirurgical Knowledge, 1, 119. Google Scholar Barritt, D.W. & Jordan, S.C. (1960) Anticoagulant drugs in the treatment of pulmonary embolism. Lancet, 1, 1309–1312. 10.1016/S0140-6736(60)92299-6 CASPubMedWeb of Science®Google Scholar Bauer, G. (1940) A venographic study of thromboembolism problems. Acta Chirurgica Scandinavica, 84, 1–7. Google Scholar Bauer, G. (1942) A roentgenological and clinical study of the sequels of thrombosis. Acta Chirurgica Scandinavica, 86, 1–106. Google Scholar Bennet, R. (1891) The diseases of the Bible, Edition 2. The Religious Tract Society, London. Google Scholar Bergqvist, D., Lindgren, B., Matzsch, T. (1996) Comparison of the cost of preventing post-operative deep vein thrombosis with either unfractionated or low molecular heparin. British Journal of Surgery, 83, 1548–1552. 10.1002/bjs.1800831117 CASPubMedWeb of Science®Google Scholar Bern, M.M., Bothe, A., Bistrian, B., Champagne, C.D., Keane, M.S., Blackburn, G. (1986) Prophylaxis against central vein thrombosis. Surgery, 99, 216–220. CASPubMedWeb of Science®Google Scholar Bertina, R.M., Koeleman, B.P.C., Koster, T., Rosendaal, F.R., Dirven, R.J., De Ronde, H., Van Der Velden, P.A., Reitsma, P.H. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature, 369, 64–67. 10.1038/369064a0 CASPubMedWeb of Science®Google Scholar Best, C.H. (1959) Preparation of heparin and its use in the first clinical cases. Circulation, 19, 79–83. 10.1161/01.CIR.19.1.79 PubMedWeb of Science®Google Scholar Biggs, R. & Denson, K.W.E. (1967) Standardisation of the prothrombin time for the control of anticoagulant therapy. British Medical Journal, 1, 84–88. 10.1136/bmj.1.5532.84 CASPubMedWeb of Science®Google Scholar Browse, N. (1972) The 125I. fibrinogen uptake test. Archives of Surgery, 104, 160–163. 10.1001/archsurg.1972.04180020040007 CASPubMedWeb of Science®Google Scholar Butt, H.R., Allen, E.U., Bollman, J.L. (1941) A preparation from spoiled sweet clover C3, 31methylene-bis-(4 hydroxy-coumarin) which prolongs coagulation and prothrombin time of 120 blood: preliminary report of experiments and clinical studies. Proceedings of the staff meetings. Mayo Clinic, 16, 388–395. CASGoogle Scholar Byrne, J.J. (1955) Phlebitis: a study of 748 cases at the Boston City Hospital. New England Journal of Medicine, 253, 579–586. 10.1056/NEJM195510062531401 PubMedWeb of Science®Google Scholar Campbell, H.A. & Link, K.P. (1941) Studies on the hemorrhagic sweet clover disease. IV. The isolation and crystallization of the hemorrhagic agent. Journal of Biological Chemistry, 138, 21–33. CASWeb of Science®Google Scholar Campbell, H.A., Roberts, W.L., Smith, W.K., Link, K.P. (1940) Studies on the hemorrhagic sweet clover disease. I. The preparation of hemorrhagic concentrates. Journal of Biological Chemistry, 136, 47–55. CASWeb of Science®Google Scholar Clagett, G.P., Anderson, Jr, F.A., Geerts, W., Heit, J., Knudson, M. (1998) Prevention of venous thromboembolism. Chest, 114, 531S–560S. 10.1378/chest.114.5_Supplement.531S CASPubMedWeb of Science®Google Scholar Collins, R., Scrimgeour, A., Yusuf, S. (1988) Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopaedic and urologic surgery. New England Journal of Medicine, 318, 1162–1173. 10.1056/NEJM198805053181805 PubMedWeb of Science®Google Scholar Comp, P.C. & Esmon, C.T. (1984) Recurrent venous thromboembolism in patients with a partial deficiency of protein S. New England Journal of Medicine, 311, 1525–1528. 10.1056/NEJM198412133112401 PubMedWeb of Science®Google Scholar Contejean, C. (1896) Nouvelles remarques critiques au sujet du role du foie et de la masse intestinale sur l'action anticoagulante des injections intravasculaires de peptone chez le chien. CR Séances Society of Biology, 48, 753–755. Google Scholar Crafoord, C. (1939) Heparin and postoperative thrombosis. Acta Chirurgia Scandinavia, 82, 319–323. Google Scholar Dahlbäck, B., Carlsson, M., Svensson, P.J. (1993) Familial thrombophilia due to a previously unrecognised mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proceedings of the National Academy of Sciences of the United States of America, 90, 1004–1008. 10.1073/pnas.90.3.1004 CASPubMedGoogle Scholar De Bakey, M.E. (1954) Collective review: a critical evaluation of the problems of thromboembolism (John Calmers Da Costa oration). International Abstracts of Surgery, 98, 1–27. CASPubMedWeb of Science®Google Scholar de Saint Pathus (1932) Les miracles de Saint Louis. In: Classiques Français de Moyen Age, (ed. by P.B. Fay), pp. 23–26. Honoré Champion, Paris. Google Scholar Dexter, L. (1973) The chair and venous thrombosis. Transactions of the American Clinical Climatological Association, 84, 1–15. CASPubMedGoogle Scholar Dexter, L. & Folch-Pi, W. (1974) Venous thrombosis. An account of the first documented case. Journal of the American Medical Association, 228, 195–196. 10.1001/jama.228.2.195 PubMedWeb of Science®Google Scholar Dougherty, J. & Homans, J. (1940) Venography, a clinical study. Surgery, Gynecology and Obstetrics, 71, 697–710. Google Scholar Doyon, M. (1910) Sécrétion d'antithrombine hépatique sans addition de substances étrangères au sang. CR Séances Societé Biologique, 68, 752–753. CASGoogle Scholar Duxbury, B.McD. (1982) The therapeutic control of anticoagulant therapy. British Medical Journal, 284, 592–597. 10.1136/bmj.284.6329.1634-c PubMedGoogle Scholar Egeberg, O. (1965) Inherited antithrombin deficiency causing thrombophilia. Thrombosis et Diathesis Haemorrhagica, 13, 516–520. CASPubMedWeb of Science®Google Scholar Faioni, E.M., Franchi, F., Asti, D., Sacchi, E., Bernardi, F., Mannucci, P.M. (1993) Resistance to activated protein C in nine thrombophilic families: interference in a protein S functional assay. Thrombosis and Haemostasis, 70, 1067–1071. PubMedWeb of Science®Google Scholar Fay, P.B. (ed.) (1932) Classiques Français de Moyen Age, pp. 23–26. Honoré Champion, Paris. Google Scholar Ferrier, J. (1810) An affectation of the lymphatic vessels hitherto misunderstood. In: Medical Histories and Reflections, III. Google Scholar Findley, P. (1912) Puerperal thrombophlebitis. American Journal of Obstetrics, 16, 987–995. Google Scholar Francis, C.W., Marder, V.J., Evarts, C.M., Yaukoolbodi, S. (1983) Two-step warfarin therapy: prevention of post-operative venous thrombosis without excessive bleeding. Journal of the American Medical Association, 249, 374–378. PubMedWeb of Science®Google Scholar Geerts, W.H., Heit, J.A., Clagett, P., Pineo, F., Colwell, C.W., Anderson, Jr, F.A., Wheeler, H.W. (2001) Prevention of venous thrombembolism. Chest, 119, Suppl, 132S–175S . 10.1378/chest.119.1_suppl.132S CASPubMedWeb of Science®Google Scholar Griffin, J.H., Evatt, B., Zimmerman, T., Kleiss, A., Wideman, C. (1981) Deficiency of protein C in congenital thrombotic disease. Journal of Clinical Investigation, 68, 1370–1373. 10.1172/JCI110385 CASPubMedWeb of Science®Google Scholar Griffin, J.H., Evatt, B., Wideman, C., Fernandez, J.A. (1993) Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood, 82, 1989–1993. 10.1182/blood.V82.7.1989.1989 CASPubMedWeb of Science®Google Scholar Haeger, K. (1969) Problems of acute deep vein thrombosis. The interpretation of signs and symptoms. Angiology, 20, 219–223. 10.1177/000331976902000406 PubMedWeb of Science®Google Scholar Haycraft, J.B. (1884) On. the action of a secretion obtained from the medicinal leech on the coagulation of the blood. Proceedings of the Royal Society of London, 36, 478–487. 10.1098/rspl.1883.0135 Google Scholar Hellemons, B.S.P., Langerberg, M., Lodder, J., Version Meer, F., Schouten, H.J.A., Lemmens, TH., Van Ree, J.W., Knottnerus, J.A. (1999) Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care. British Medical Journal, 319, 958–964. 10.1136/bmj.319.7215.958 CASPubMedWeb of Science®Google Scholar Hewson, W. (1846) The Works of William Hewson, F.R.S. (ed. by G. Gulliver). Sydenham Society, London. Google Scholar Hirsh, J., Dalen, J.E., Anderson, D.R., Poller, L., Bussy, H., Ansell, J., Deykin, D., Brandt, J. (1998) Oral anticoagulants. Mechanism of action; Clinical effectiveness and therapeutic range. Chest, 114, 445–469S. 10.1378/chest.114.5_Supplement.445S CASPubMedWeb of Science®Google Scholar Howell, W.H. (1925) The purification of heparin and its presence in blood. American Journal of Physiology, 63, 434. Google Scholar Howell, W.H. & Holt, E. (1918) Two new factors in coagulation, heparin and pro-antithrombin. American Journal of Physiology, 47, 328–342. CASGoogle Scholar Hull, J. (1800) An essay on phlegmasia dolens. R & W Dean, Manchester. Google Scholar Hull, R.D., Delmore, T., Carter, I., Hirsh, J., Genton, E., Gent, M., Turpie, G., McLoughlin, D. (1982) Different intensities of oral anticoagulant treatment of proximal vein thrombosis. New England Journal of Medicine, 329, 524–529. Google Scholar Hull, R.D., Hirsh, J., Carter, C.J., Jay, R.M., Ockelford, P.A., Buller, H.R., Turpie, A.G., Powers, P., Kinch, D., Dodd, P.E. (1985) Diagnostic efficacy of impedance phlethysmography for clinically suspected deep vein thrombosis. A randomized trial. Annals of Internal Medicine, 102, 21–28. 10.7326/0003-4819-102-1-21 CASPubMedWeb of Science®Google Scholar Hull, R.D., Raskob, G.E., Pineo, G.F. (1997) Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective. Archives of Internal Medicine, 157, 298–303. 10.1001/archinte.157.3.298 CASPubMedWeb of Science®Google Scholar Hunter, J. (1793) Observations on the inflammation of the internal coats of veins. Transactions of the Society for the Improvement of Medical and Chirurgical Knowledge, 1, 18–25. PubMedGoogle Scholar Hyers, T.M., Agnelli, G., Hull, R.D., Weg, J.G., Morris, T.A., Samama, M., Tapson, V. (2001) Antithrombotic therapy for venous thromboembolic disease. Chest, 119, Suppl, 176S–193S . 10.1378/chest.119.1_suppl.176S PubMedWeb of Science®Google Scholar International Committee on Thrombosis Haemostasis/International Committee for Standardization in Haematology (1979) Prothrombin time standardisation: report of the expert panel on oral anticoagulant control. Thrombosis and Haemostasis, 42, 1073–1114. PubMedGoogle Scholar Imperiale, T.F. & Speroff, T. (1994) A meta-analysis of methods to prevent venous thromboembolism following total hip replacement. Journal of the American Medical Association, 271, 1780–1785. PubMedWeb of Science®Google Scholar Johnson, E.A., Kirkwood, T.B.L., Stirling, Y. (1976) Four heparin prep: anti-Xa potentiation effect of heparin after subcutaneous injection. Thrombosis and Haemostasis, 35, 586–591. CASPubMedWeb of Science®Google Scholar Johnson, T. (1678) The works of the famous chirurgeon, Ambrose Perey. Clark, London. Google Scholar Jorpes, E. (1935) The chemistry of heparin. Biochemical Journal, 29, 1817–1822. 10.1042/bj0291817 CASPubMedGoogle Scholar Kakkar, V. (1972) The diagnosis of deep vein thrombosis using the 125I fibrinogen test. Archives of Surgery, 104, 152–159. 10.1001/archsurg.1972.04180020032006 PubMedWeb of Science®Google Scholar Kalafatis, M., Rand, M.D., Mann, K.G. (1994) The mechanism of inactivation of human factor V and human factor Va by activated protein C. Journal of Biological Chemistry, 269, 31869–31880. CASPubMedWeb of Science®Google Scholar Kalafatis, M., Bertina, R.M., Rand, M.D., Mann, K.G. (1995) Characterization of the molecular defect in factor VR506Q. Journal of Biological Chemistry, 270, 4053–4057.DOI: 10.1074/jbc.270.8.4053 10.1074/jbc.270.8.4053 CASPubMedWeb of Science®Google Scholar Kirkwood, T.B.L. (1983) Calibration of reference thromboplastin and standardisation of the prothrombin time ratio. Thrombosis and Haemostasis, 36, 230–236. Google Scholar Koster, T., Rosendaal, F.R., De Ronde, H., Briët, E., Vandenbroucke, J.P., Bertina, R.M. (1993) Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet, 342, 1503–1506. 10.1016/S0140-6736(05)80081-9 CASPubMedWeb of Science®Google Scholar Lensing, A.W. & Hirsh, J. (1993) 125I-fibrinogen leg scanning: reassessment of its role for the diagnosis of venous thrombosis in post-operative patients. Thrombosis and Haemostasis, 69, 2–7. CASPubMedWeb of Science®Google Scholar Lensing, A.W., Prandoni, P., Brandjes, D., Huisman, P.M., Vigo, M., Tomasella, G., Krekt, J., Ten Cate, J.W., Huisman, M.V., Buller, H.R. (1989) Detection of deep vein thrombosis by real-time B-mode ultrasonography. New England Journal of Medicine, 320, 342–345. 10.1056/NEJM198902093200602 PubMedWeb of Science®Google Scholar Levine, M., Hirsh, J., Gent, M. (1994) Double blind randomized trial of a very low-dose warfarin for prevention of thromboembolism in stage IV breast cancer. Lancet, 343, 886–889. 10.1016/S0140-6736(94)90008-6 CASPubMedWeb of Science®Google Scholar Levret, A. (1766) L'art des acouchements, 3rd edn. Didot, Paris. Google Scholar Link, K.P. (1959) The discovery of dicumarol and its sequels. Circulation, 19, 97–107. 10.1161/01.CIR.19.1.97 CASPubMedWeb of Science®Google Scholar Lockwood, D.P. (1951) Ugo Benzi. medieval philosopher and physician, pp. 1376–1439. University Press, Chicago. Google Scholar Loeliger, E.A., Poller, L., Samama, M., Verstraete, M. (1984) Questions and answers on prothrombin time standardisation in oral anticoagulant control. Thrombosis and Haemostasis, 54, 514–518. Google Scholar McLean, J. (1916) The thromboplastic action of cephalin. American Journal of Physiology, 41, 250–257. Google Scholar Miale, J.B. & La Fond, D.J. (1967) Prothrombin time standardisation – 1963 Prothrombin time test survey. College of American Pathologist Standard Subcommittee on Coagulation. American Journal of Clinical Pathology, 47, 40–46. 10.1093/ajcp/47.1.40 CASPubMedWeb of Science®Google Scholar Mohr, D.N., Silverstein, M.D., Murtaugh, P.A., Imperiale, T.F., Speroff, T. (1993) Prophylactic agents for venous thrombosis in elective hip surgery. Meta-analysis of studies using venographic assessment. Archives of Internal Medicine, 153, 2221–2228. PubMedWeb of Science®Google Scholar Nordstrom, M., Lindblad, B., Bergqvist, D., Kjellstrom, T. (1992) A prospective study of the incidence of deep-vein thrombosis within a defined urban population. Journal of Internal Medicine, 232, 155–160. 10.1111/j.1365-2796.1992.tb00565.x PubMedWeb of Science®Google Scholar Ockelford, P.A., Patterson, J., John, A.S. (1989) A double blind randomized placebo control trial of thromboprophylaxis in major elective surgery using once daily injections of a low-molecular weight heparin (Fragmin). Thrombosis and Haemostasis, 62, 1046–1049. PubMedWeb of Science®Google Scholar Owen, C.A. & Bowie, E.J.W. (1996) The history of the development of oral anticoagulant drugs. In: Oral Anticoagulants (ed. by L. Poller & J. Hirsh), pp. 1–8. Arnold, London. Google Scholar Poller, L. (1964) The standardisation of oral anticoagulant treatment – the Manchester Regional Thromboplastin Scheme. British Medical Journal, ii, 565–566. 10.1136/bmj.2.5408.565 Web of Science®Google Scholar Poller, L., McKernan, A., Thomson, J.M., Elstein, M., Hirsch, P.J., Jones, J.B. (1987) Fixed minidose warfarin: a new approach to prophylaxis against venous thrombosis after major surgery. British Medical Journal, 295, 1309–1312. 10.1136/bmj.295.6609.1309 CASPubMedWeb of Science®Google Scholar Poller, L., Van Den Besselaar, A.M.H.P., Jespersen, J., Tripodi, A., Houghton, D. for the European Concerted Action on Anticoagulation (ECAA) (1998a) A comparison of artificially depleted, lyophilized coumarin and fresh coumarin plasmas in thromboplastin calibration. British Journal of Haematology, 101, 462–467.DOI: 10.1046/j.1365-2141.1998.00728.x 10.1046/j.1365-2141.1998.00728.x CASPubMedWeb of Science®Google Scholar Poller, L., Van Den Besselaar, A.M.H.P., Jespersen, J., Tripodi, A., Houghton, D. for the European Concerted Action on Anticoagulation (ECAA) (1998b) Field studies of coagulometer effects on the ISI of ECAA thromboplastins. Thrombosis and Haemostasis, 80, 615–623. CASPubMedWeb of Science®Google Scholar Poller, L., Shiach, C.R., MacCallum, P.K., Johansen, A.M., Münster, A.M., Magalhães, A., Jespersen, J. for the European Concerted Action on Anticoagulation (1998c) Multicentre randomized study of computerised anticoagulant dosage. Lancet, 352, 1505–1509.DOI: 10.1016/s0140-6736(98)04147-6 10.1016/s0140-6736(98)04147-6 CASPubMedWeb of Science®Google Scholar Poort, S.R., Rosendaal, F.R., Reitsma, P.M., Bertina, R.M. (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood, 88, 3698–3703. 10.1182/blood.V88.10.3698.bloodjournal88103698 CASPubMedWeb of Science®Google Scholar Popkin, R.J. (1962) The post-thrombophlebitic syndrome. Charles C Thomas, Springfield. Google Scholar Prandoni, P. & Mannucci, P.M. (1999) Deep vein thrombosis of the lower limbs: diagnosis and management. Baillieres Best Practice in Clinical Hematology, 12, 533–554. 10.1053/beha.1999.0039 CASPubMedWeb of Science®Google Scholar Roderick, L.M. (1929) The pathology of sweet clover disease in cattle. Journal of the American Veterinary Medical Association, 74, 314–315. Google Scholar Roderiguez Castro, A. (1604) De universa mulierum morborum medicina. Froberiana, Hamburg. Google Scholar Rokitansky, C. (1852) Pathological anatomy, IV, 336. Sydenham Society, London. Google Scholar Rosendaal, F.R., Cannengieter, S.C., Van Der Meer, F.J.M., Briët, E. (1993 )A method to determine the optimal intensity of oral anticoagulant therapy. Thrombosis and Haemostasis, 69, 236–239. 10.1055/s-0038-1651587 CASPubMedWeb of Science®Google Scholar Samama, M., Bernard, P., Bonnardot, J.P. (1988) Low molecular weight heparin compared with unfractionated heparin in prevention of postoperative thrombosis. British Journal of Surgery, 75, 128–131. 10.1002/bjs.1800750213 PubMedWeb of Science®Google Scholar Schmidt-Mulheim, A. (1880) Beiträge zur Kenntnis des Peptons und seiner physiologischen Bedeutung. Arch für Anatomie und Physiologie. Physiologische Abteilung, 33, 56. Google Scholar Schofield, F.W. (1924) Damaged sweet clover. The cause of a new disease in cattle simulating hemorrhagic septicemia and blackleg. Journal of the American Veterinary Medical Association, 64, 553–575. Google Scholar Schwartz, H.P., Fischer, M., Hopmeier, P., Batard, M., Griffin, J. (1984) Plasma protein S deficiency in familial thrombotic disease. Blood, 64, 1297–1300. PubMedWeb of Science®Google Scholar Sevitt, S. & Gallagher, N.G. (1959) Prevention of venous thrombosis and pulmonary embolism in injured patients; a trial of anticoagulant prophylaxis with phenindione in middle-aged and elderly patients with fractured necks of femur. Lancet, ii, 981–989. 10.1016/S0140-6736(59)91464-3 CASGoogle Scholar Sproul, E.E. (1938) Carcinoma and venous thrombosis: the frequency of associations of carcinoma in the body or tail of the pancreas with multiple venous thrombosis. American Journal of Cancer, 34, 566–585. Google Scholar Starr, A., Frank, H.A., Fine, J. (1942) The venographic diagnosis of thrombophlebitis of the lower extremities. Journal of the American Medical Association, 118, 1192–1195. 10.1001/jama.1942.02830140022007 Google Scholar Taberner, D.A., Poller, L., Burslem, R.W., Jones, J.B. (1978) Oral anticoagulants controlled by the British comparative thromboplastin versus low-dose heparin in prophylaxis of deep vein thrombosis. British Medical Journal, 1, 272–274. 10.1136/bmj.1.6108.272 PubMedWeb of Science®Google Scholar Trousseau, A. (1866) Phlegmasia alba dolens. Clinique Medical de l'Hotel-Dieu, 3, 654–712. Google Scholar Virchow, R. (1860) Cellular pathology. Churchill, London. Google Scholar World Health Organization (1983) Expert Committee of Biological Standardisation 33rd Report. WHO Technical Series, 700, 19–30. Google Scholar Wiseman, R. (1676). Severall Chirurgicall Treatises, p. 64. Norton and Macock, London. Google Scholar Wright, I.S., Marple, C.D., Beck, D.F. (1954) Myocardial infarction: Its clinical significance and treatment with anticoagulants. A study of 1031 cases. Grune Stratton, New York. Google Scholar Citing Literature Volume114, Issue2August 2001Pages 258-270 ReferencesRelatedInformation
Referência(s)